Atossa Therapeutics, Inc. (ATOS)
4.94
-0.04
(-0.80%)
USD |
NASDAQ |
Apr 10, 16:00
5.00
+0.06
(+1.21%)
After-Hours: 20:00
Atossa Therapeutics Free Cash Flow : -29.78M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Celldex Therapeutics, Inc. | -213.66M |
| Plus Therapeutics, Inc. | -20.84M |
| Abeona Therapeutics, Inc. | -84.30M |
| Cell Source, Inc. | -- |
| Kiora Pharmaceuticals, Inc. | -10.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.54M |
| Cash from Investing (Quarterly) | -0.007M |
| Free Cash Flow Per Share (Quarterly) | -1.225 |
| Free Cash Flow to Equity (Quarterly) | -10.55M |
| Free Cash Flow to Firm (Quarterly) | -10.55M |
| Free Cash Flow Yield | -15.56% |